215 related articles for article (PubMed ID: 30079778)
1. Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI: a systematic review and meta-analysis of 14 randomized trials.
Li Y; Liu H; Peng W; Song Z
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):855-865. PubMed ID: 30079778
[TBL] [Abstract][Full Text] [Related]
2. Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
Yi B; Luo J; Jiang Y; Mo S; Xiao X; Chen X; Rong J
Angiology; 2020 Aug; 71(7):609-615. PubMed ID: 32295385
[TBL] [Abstract][Full Text] [Related]
3. Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
Zhu H; Xu X; Fang X; Zheng J; Chen T; Huang J
Medicine (Baltimore); 2019 Jan; 98(3):e14165. PubMed ID: 30653160
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
Zhao XT; Zhang CF; Liu QJ
BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
[TBL] [Abstract][Full Text] [Related]
5. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Xu L; Wang L; Li K; Zhang Z; Sun H; Yang X
Drug Des Devel Ther; 2019; 13():1389-1400. PubMed ID: 31118574
[No Abstract] [Full Text] [Related]
6. Nicorandil for the prevention of contrast-induced nephropathy: A meta-analysis of randomized controlled trials.
Ma X; Li X; Jiao Z; Zhang Y
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29283501
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients.
Yi B; Mo S; Jiang Y; Yi D; Luo J; Chen X; Rong J
J Interv Cardiol; 2020; 2020():4527816. PubMed ID: 32982608
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil Reduces the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography/Intervention - Systematic Review and Meta-Analysis of Randomized Controlled Trials Including GRADE Qualification.
Pranata R; Vania R; Alkatiri AA; Firman D; Lukito AA
Cardiovasc Revasc Med; 2020 Sep; 21(9):1121-1127. PubMed ID: 31959562
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.
Li J; Xu X; Zhou X; Dai J; Ma L; Chen C; Li X; Mao W
Expert Opin Drug Saf; 2019 Jun; 18(6):537-547. PubMed ID: 31117845
[No Abstract] [Full Text] [Related]
10. Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials.
Pei H; Wu Y; Wei Y; Yang Y; Teng S; Zhang H
PLoS One; 2014; 9(12):e115500. PubMed ID: 25551671
[TBL] [Abstract][Full Text] [Related]
11. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Ji Z; Zhang R; Lu W; Ma G; Qu Y
Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris.
Thomas S; Gokhale R; Boden WE; Devereaux PJ
Can J Cardiol; 2013 Apr; 29(4):472-82. PubMed ID: 23010084
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of nicorandil on contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Li S; Wang L; Liu Y; Hu Q
Intern Med J; 2018 Aug; 48(8):957-963. PubMed ID: 29740934
[TBL] [Abstract][Full Text] [Related]
14. Preventive Effects of Nicorandil Against Contrast-Induced Nephropathy in Patients With Moderate Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
Zhang P; Li WY; Yang SC; Fu NK; Liu XG; Zhang X; Cong HL; Lin WH; Tian FS; Lu CZ; Zhang J
Angiology; 2020 Feb; 71(2):183-188. PubMed ID: 30987432
[TBL] [Abstract][Full Text] [Related]
15. Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials.
Shi L; Chen L; Qi G; Tian W; Zhao S
Am J Cardiovasc Drugs; 2020 Apr; 20(2):191-198. PubMed ID: 31423544
[TBL] [Abstract][Full Text] [Related]
16. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials.
Wang X; Geng J; Zhu H; Xing C
Oncotarget; 2018 Feb; 9(14):11837-11845. PubMed ID: 29545940
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
Pursnani S; Korley F; Gopaul R; Kanade P; Chandra N; Shaw RE; Bangalore S
Circ Cardiovasc Interv; 2012 Aug; 5(4):476-90. PubMed ID: 22872053
[TBL] [Abstract][Full Text] [Related]
20. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
